Parents learn before age 5 through genetic and behavioral screening that their child is at an increased risk for Anorexia Nervosa. Researched methods apply early intervention therapy to prevent development of the disorder in 90% of cases.

 

Individuals hospitalized for Anorexia Nervosa are given a new class of medications and evidence-based behavioral therapy that reduces their hospital stay from 3 weeks to 5 days and their partial hospitalizations from 3 months to 1 month. This new class of medications is made possible by understanding the unique biological pathways involved in each disorder and rebuilds normal function.

 

Patients and families are provided with monitoring applications through wearables and mobile devices to trend biometric signals that detect distress weeks or months before the distress can be seen through eating behaviors. New interventions that extend FBT and DBT structured dialogs with families keep obsessive thoughts from becoming problematic.

 

Professional care providers and patients use biomarkers beyond weight to track progress towards key milestones understood through a biomarker (imaging, labs, wearables) using evidence-based approaches towards achieving patient psychological outcomes.

 

Patients, payers, and referring facilities receive reports on the quality of care at locations through outcome-based statistics including medical outcomes and patient- and family-reported metrics. This drives groups to adopt best practices and focus on developing new approaches through experimentation in order to differentiate their treatment services in positive ways.

 

Patients with eating disorders and their families with novel ideas about their illness can post their hypotheses regarding biology and potential successful interventions. Researchers and clinicians are able to rapidly recruit a set of volunteers to test them through surveys and design of interventions that can improve recovery outcomes.